Botanix Pharmaceuticals' (ASX:BOT) Vince Ippolito speaks to Proactive's Andrew Scott from the ASX Small and Mid-Cap Conference. Botanix is a clinical stage synthetic cannabinoid pharmaceutical company with a targeted pipeline of dermatology and antimicrobial products.
Botanix Pharmaceuticals with Proactive at the ASX Small and Mid-Cap Conference